{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:36:14Z","timestamp":1781642174247,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Bureau of Xiangcheng District, Suzhou","award":["No. XJ201706"],"award-info":[{"award-number":["No. XJ201706"]}]},{"name":"Health Commission of Suzhou","award":["No. GSWS2019090"],"award-info":[{"award-number":["No. GSWS2019090"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It remains unclear whether leukocyte-related parameters could be used as biomarkers to differentiate metabolically unhealthy overweight\/obesity (MUO) from metabolically healthy overweight\/obesity (MHO). We aimed to examine the differences in the distribution of leukocyte-related parameters between older adults with MHO and MUO and the correlations of leukocyte-related parameters with individual components of metabolic abnormality. In the Weitang Geriatric Diseases Study on older Chinese adults aged 60\u00a0years or above, 404 individuals with MHO and 480 with MUO contributed to the analysis. Overweight\/obesity was defined as body mass index (BMI) of 25\u00a0kg\/m<jats:sup>2<\/jats:sup> or more. MHO and MUO were discriminated based on the Adult Treatment Panel III (ATP III) criteria. Leukocyte-related parameters were assessed using an automated hematology analyzer. All leukocyte-related parameters except monocytes were elevated in MUO group compared with MHO group (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The prevalence of MUO increased by 24% with each 10<jats:sup>9<\/jats:sup>\/L increase of leukocytes after adjusting for confounders in the multiple-adjusted model (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) and each unit elevation of other parameters except lymphocytes and monocytes were significantly associated with the presence of MUO (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Trend tests revealed a linear trend for the association between MUO and all the leukocyte-related parameters (all <jats:italic>P<\/jats:italic> for trend\u2009&lt;\u20090.05). Significant interactions between leukocyte-related parameters and sex on the presence of MUO were observed (all <jats:italic>P<\/jats:italic> value for interaction\u2009&lt;\u20090.05). Higher leukocyte-related parameters were found in patients with MUO than those with MHO and were associated with higher prevalence of MUO which seems to be sex-dependent. Further studies are needed to see whether these parameters could be used as biomarkers for the screening or diagnosis for MUO in clinical or public health practice.<\/jats:p>","DOI":"10.1038\/s41598-021-84367-7","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T11:04:11Z","timestamp":1614251051000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Leukocyte related parameters in older adults with metabolically healthy and unhealthy overweight or obesity"],"prefix":"10.1038","volume":"11","author":[{"given":"Shan-Shan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"84367_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.metabol.2018.11.009","volume":"92","author":"C Iacobini","year":"2019","unstructured":"Iacobini, C., Pugliese, G., Blasetti Fantauzzi, C., Federici, M. & Menini, S. Metabolically healthy versus metabolically unhealthy obesity. Metabolism 92, 51\u201360. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.009 (2019).","journal-title":"Metabolism"},{"key":"84367_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.numecd.2018.06.015","volume":"28","author":"A Jia","year":"2018","unstructured":"Jia, A. et al. Prevalence and cardiometabolic risks of normal weight obesity in Chinese population: A nationwide study. Nutr. Metab. Cardiovasc. Dis. 28, 1045\u20131053. https:\/\/doi.org\/10.1016\/j.numecd.2018.06.015 (2018).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"84367_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091199","author":"AF Ctoi","year":"2018","unstructured":"Ctoi, A. F. et al. Metabolically healthy versus unhealthy morbidly obese: Chronic inflammation, nitro-oxidative stress, and insulin resistance. Nutrients https:\/\/doi.org\/10.3390\/nu10091199 (2018).","journal-title":"Nutrients"},{"key":"84367_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/eurheartj\/ehs174","volume":"34","author":"FB Ortega","year":"2013","unstructured":"Ortega, F. B. et al. The intriguing metabolically healthy but obese phenotype: Cardiovascular prognosis and role of fitness. Eur. Heart J. 34, 389\u2013397. https:\/\/doi.org\/10.1093\/eurheartj\/ehs174 (2013).","journal-title":"Eur. Heart J."},{"key":"84367_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/met.2018.0132","volume":"17","author":"KA Christou","year":"2019","unstructured":"Christou, K. A. et al. Metabolically healthy obesity is characterized by a proinflammatory phenotype of circulating monocyte subsets. Metab. Syndr. Relat. Disord. 17, 259\u2013265. https:\/\/doi.org\/10.1089\/met.2018.0132 (2019).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"84367_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11154-013-9252-x","volume":"14","author":"CM Phillips","year":"2013","unstructured":"Phillips, C. M. Metabolically healthy obesity: Definitions, determinants and clinical implications. Rev. Endocr. Metab. Disord. 14, 219\u2013227. https:\/\/doi.org\/10.1007\/s11154-013-9252-x (2013).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"84367_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.metabol.2019.01.003","volume":"93","author":"M Kouvari","year":"2019","unstructured":"Kouvari, M. et al. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study. Metabolism 93, 18\u201324. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.003 (2019).","journal-title":"Metabolism"},{"key":"84367_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/CH-2011-1417","volume":"48","author":"A Vaya","year":"2011","unstructured":"Vaya, A. et al. Metabolic alterations in morbid obesity. Influence on the haemorheological profile. Clin. Hemorheol. Microcirc. 48, 247\u2013255. https:\/\/doi.org\/10.3233\/CH-2011-1417 (2011).","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"84367_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/oby.21482","volume":"24","author":"AP Doumatey","year":"2016","unstructured":"Doumatey, A. P. et al. Proinflammatory and lipid biomarkers mediate metabolically healthy obesity: A proteomics study. Obes. (Silver Spring) 24, 1257\u20131265. https:\/\/doi.org\/10.1002\/oby.21482 (2016).","journal-title":"Obes. (Silver Spring)"},{"key":"84367_CR10","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1210\/jc.2005-0482","volume":"90","author":"AD Karelis","year":"2005","unstructured":"Karelis, A. D. et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J. Clin. Endocrinol. Metab. 90, 4145\u20134150. https:\/\/doi.org\/10.1210\/jc.2005-0482 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"84367_CR11","doi-asserted-by":"publisher","first-page":"E1610","DOI":"10.1210\/jc.2013-2038","volume":"98","author":"CM Phillips","year":"2013","unstructured":"Phillips, C. M. & Perry, I. J. Does inflammation determine metabolic health status in obese and nonobese adults?. J. Clin. Endocrinol. Metab. 98, E1610-1619. https:\/\/doi.org\/10.1210\/jc.2013-2038 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"84367_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3748\/wjg.v10.i8.1115","volume":"10","author":"N Ilhan","year":"2004","unstructured":"Ilhan, N., Ilhan, N., Ilhan, Y., Akbulut, H. & Kucuksu, M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World J. Gastroenterol. 10, 1115\u20131120. https:\/\/doi.org\/10.3748\/wjg.v10.i8.1115 (2004).","journal-title":"World J. Gastroenterol."},{"key":"84367_CR13","doi-asserted-by":"publisher","first-page":"456456","DOI":"10.1155\/2012\/456456","volume":"2012","author":"I Alam","year":"2012","unstructured":"Alam, I., Ng, T. P. & Larbi, A. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm. 2012, 456456. https:\/\/doi.org\/10.1155\/2012\/456456 (2012).","journal-title":"Mediators Inflamm."},{"key":"84367_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.archger.2018.01.008","volume":"76","author":"CW Pan","year":"2018","unstructured":"Pan, C. W. et al. Evaluating health-related quality of life impact of chronic conditions among older adults from a rural town in Suzhou China. Arch. Gerontol. Geriatr. 76, 6\u201311. https:\/\/doi.org\/10.1016\/j.archger.2018.01.008 (2018).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"84367_CR15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1080\/13607863.2017.1339779","volume":"22","author":"YJ Gu","year":"2018","unstructured":"Gu, Y. J. et al. Tea consumption is associated with cognitive impairment in older Chinese adults. Aging Ment. Health 22, 1232\u20131238. https:\/\/doi.org\/10.1080\/13607863.2017.1339779 (2018).","journal-title":"Aging Ment. Health"},{"key":"84367_CR16","doi-asserted-by":"publisher","first-page":"17301","DOI":"10.1038\/srep17301","volume":"5","author":"CW Pan","year":"2015","unstructured":"Pan, C. W. et al. Cognitive dysfunction and health-related quality of life among older Chinese. Sci. Rep. 5, 17301. https:\/\/doi.org\/10.1038\/srep17301 (2015).","journal-title":"Sci. Rep."},{"key":"84367_CR17","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 894, 1\u2013253 (2000)."},{"key":"84367_CR18","doi-asserted-by":"publisher","unstructured":"Expert Panel on Detection, E. & Treatment of High Blood Cholesterol in, A. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285, 2486\u20132497, https:\/\/doi.org\/10.1001\/jama.285.19.2486 (2001).","DOI":"10.1001\/jama.285.19.2486"},{"key":"84367_CR19","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1038\/oby.2010.332","volume":"19","author":"RP Wildman","year":"2011","unstructured":"Wildman, R. P. et al. Body size phenotypes and inflammation in the Women\u2019s health initiative observational study. Obesity (Silver Spring) 19, 1482\u20131491. https:\/\/doi.org\/10.1038\/oby.2010.332 (2011).","journal-title":"Obesity (Silver Spring)"},{"key":"84367_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/oby.2008.565","volume":"17","author":"LA Lynch","year":"2009","unstructured":"Lynch, L. A. et al. Are natural killer cells protecting the metabolically healthy obese patient?. Obesity (Silver Spring) 17, 601\u2013605. https:\/\/doi.org\/10.1038\/oby.2008.565 (2009).","journal-title":"Obesity (Silver Spring)"},{"key":"84367_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12876-018-0814-y","volume":"18","author":"MK Baeg","year":"2018","unstructured":"Baeg, M. K., Ko, S. H., Ko, S. Y., Jung, H. S. & Choi, M. G. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: A large-scale cross-sectional study. BMC Gastroenterol. 18, 82. https:\/\/doi.org\/10.1186\/s12876-018-0814-y (2018).","journal-title":"BMC Gastroenterol."},{"key":"84367_CR22","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/0300060516663778","volume":"44","author":"XL Wang","year":"2016","unstructured":"Wang, X. L. et al. Peripheral invariant natural killer T cell deficiency in metabolically unhealthy but normal weight versus metabolically healthy but obese individuals. J. Int. Med. Res. 44, 1272\u20131282. https:\/\/doi.org\/10.1177\/0300060516663778 (2016).","journal-title":"J. Int. Med. Res."},{"key":"84367_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1017\/thg.2018.6","volume":"21","author":"M Amini","year":"2018","unstructured":"Amini, M. et al. Blood eosinophil count and metabolic, cardiac and pulmonary outcomes: A mendelian randomization study. Twin Res. Hum. Genet. 21, 89\u2013100. https:\/\/doi.org\/10.1017\/thg.2018.6 (2018).","journal-title":"Twin Res. Hum. Genet."},{"key":"84367_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s42000-020-00201-1","volume":"19","author":"KA Christou","year":"2020","unstructured":"Christou, K. A. et al. The regulation of serum resistin levels in metabolically healthy and unhealthy obese individuals. Hormones (Athens) 19, 523\u2013529. https:\/\/doi.org\/10.1007\/s42000-020-00201-1 (2020).","journal-title":"Hormones (Athens)"},{"key":"84367_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcsm.12178","volume":"8","author":"K Boengler","year":"2017","unstructured":"Boengler, K., Kosiol, M., Mayr, M., Schulz, R. & Rohrbach, S. Mitochondria and ageing: Role in heart, skeletal muscle and adipose tissue. J. Cachexia Sarcopenia Muscle 8, 349\u2013369. https:\/\/doi.org\/10.1002\/jcsm.12178 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"84367_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.atherosclerosis.2007.08.014","volume":"197","author":"R Mazor","year":"2008","unstructured":"Mazor, R. et al. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis 197, 937\u2013943. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.08.014 (2008).","journal-title":"Atherosclerosis"},{"key":"84367_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/occmed\/52.4.213","volume":"52","author":"N Nakanishi","year":"2002","unstructured":"Nakanishi, N., Suzuki, K. & Tatara, K. White blood cell count and clustered features of metabolic syndrome in Japanese male office workers. Occup. Med. (Lond.) 52, 213\u2013218. https:\/\/doi.org\/10.1093\/occmed\/52.4.213 (2002).","journal-title":"Occup. Med. (Lond.)"},{"key":"84367_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ecl.2008.05.001","volume":"37","author":"B Razani","year":"2008","unstructured":"Razani, B., Chakravarthy, M. V. & Semenkovich, C. F. Insulin resistance and atherosclerosis. Endocrinol. Metab. Clin. N. Am. 37, 603\u2013621. https:\/\/doi.org\/10.1016\/j.ecl.2008.05.001 (2008).","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"84367_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02243-2","author":"XJ Yang","year":"2020","unstructured":"Yang, X. J. et al. Leukocyte-related parameters in older adults with metabolic syndrome. Endocrine https:\/\/doi.org\/10.1007\/s12020-020-02243-2 (2020).","journal-title":"Endocrine"},{"key":"84367_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1474-9726.2006.00224.x","volume":"5","author":"S Demissie","year":"2006","unstructured":"Demissie, S. et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell 5, 325\u2013330. https:\/\/doi.org\/10.1111\/j.1474-9726.2006.00224.x (2006).","journal-title":"Aging Cell"},{"key":"84367_CR31","doi-asserted-by":"publisher","first-page":"490613","DOI":"10.1155\/2015\/490613","volume":"2015","author":"C Lubrano","year":"2015","unstructured":"Lubrano, C. et al. Integrated haematological profiles of redox status, lipid, and inflammatory protein biomarkers in benign obesity and unhealthy obesity with metabolic syndrome. Oxid. Med. Cell Longev. 2015, 490613. https:\/\/doi.org\/10.1155\/2015\/490613 (2015).","journal-title":"Oxid. Med. Cell Longev."},{"key":"84367_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3109\/10408363.2014.992063","volume":"52","author":"A Trpkovic","year":"2015","unstructured":"Trpkovic, A. et al. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit. Rev. Clin. Lab Sci. 52, 70\u201385. https:\/\/doi.org\/10.3109\/10408363.2014.992063 (2015).","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"84367_CR33","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.4049\/jimmunol.1004054","volume":"186","author":"M Suzukawa","year":"2011","unstructured":"Suzukawa, M. et al. Leptin enhances survival and induces migration, degranulation, and cytokine synthesis of human basophils. J. Immunol. 186, 5254\u20135260. https:\/\/doi.org\/10.4049\/jimmunol.1004054 (2011).","journal-title":"J. Immunol."},{"key":"84367_CR34","doi-asserted-by":"publisher","first-page":"154735","DOI":"10.1016\/j.cyto.2019.154735","volume":"121","author":"AA Ghadge","year":"2019","unstructured":"Ghadge, A. A. & Khaire, A. A. Leptin as a predictive marker for metabolic syndrome. Cytokine 121, 154735. https:\/\/doi.org\/10.1016\/j.cyto.2019.154735 (2019).","journal-title":"Cytokine"},{"key":"84367_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9030236","author":"M Monserrat-Mesquida","year":"2020","unstructured":"Monserrat-Mesquida, M. et al. Metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants (Basel) https:\/\/doi.org\/10.3390\/antiox9030236 (2020).","journal-title":"Antioxidants (Basel)"},{"key":"84367_CR36","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2169\/internalmedicine.46.0136","volume":"46","author":"N Ishizaka","year":"2007","unstructured":"Ishizaka, N., Ishizaka, Y., Toda, E., Nagai, R. & Yamakado, M. Association between cigarette smoking, white blood cell count, and metabolic syndrome as defined by the Japanese criteria. Intern. Med. 46, 1167\u20131170. https:\/\/doi.org\/10.2169\/internalmedicine.46.0136 (2007).","journal-title":"Intern. Med."},{"key":"84367_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5114\/pm.2016.61191","volume":"15","author":"P Vichinsartvichai","year":"2016","unstructured":"Vichinsartvichai, P. & Sirirat, S. Hematologic parameters as the predictors for metabolic syndrome in perimenopausal and postmenopausal women living in urban area: A preliminary report. Prz Menopauzalny 15, 90\u201395. https:\/\/doi.org\/10.5114\/pm.2016.61191 (2016).","journal-title":"Prz Menopauzalny"},{"key":"84367_CR38","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1515\/cclm-2018-0801","volume":"57","author":"H Mangge","year":"2019","unstructured":"Mangge, H. et al. Subcutaneous adipose tissue distribution and telomere length. Clin. Chem. Lab Med. 57, 1358\u20131363. https:\/\/doi.org\/10.1515\/cclm-2018-0801 (2019).","journal-title":"Clin. Chem. Lab Med."},{"key":"84367_CR39","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/ATVBAHA.120.314508","volume":"40","author":"R Ter Horst","year":"2020","unstructured":"Ter Horst, R. et al. Sex-specific regulation of inflammation and metabolic syndrome in obesity. Arterioscler. Thromb. Vasc. Biol. 40, 1787\u20131800. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314508 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"84367_CR40","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13125","author":"AR Khalifa","year":"2017","unstructured":"Khalifa, A. R. et al. Sex-specific differences in mitochondria biogenesis, morphology, respiratory function, and ROS homeostasis in young mouse heart and brain. Physiol. Rep. https:\/\/doi.org\/10.14814\/phy2.13125 (2017).","journal-title":"Physiol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84367-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84367-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:24:33Z","timestamp":1670041473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84367-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84367"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84367-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4652"}}